Company intelligence / Profile preview

Molecular Research Center

Cincinnati, Ohio, United States

Ownership: Private
Development stage: Commercial

Overview

Molecular Research Center develops and manufactures innovative products for the isolation and analysis of RNA and DNA. Their patented single-step methods have become industry standards in molecular biology labs worldwide. The company’s founder, Piotr Chomczynski, developed the widely cited single-step RNA isolation protocol that underpins their flagship product lines such as RNAzol® RT and DNAzol®. These products are recognized globally for performance, reliability, cost-effectiveness, and sample purity.

Industry: Chemicals & Materials

Partnerships

Authorized distributors internationally (e.g., Biolinkk in India)

Beyond the preview

Go deeper on Molecular Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molecular Research Center.

Explore the full profile